DiaSorin S.p.A. (LON:0GZX)
97.82
+0.22 (0.23%)
At close: Apr 22, 2025
DiaSorin Revenue
In the year 2024, DiaSorin had annual revenue of 1.19B EUR with 3.24% growth. DiaSorin had revenue of 309.43M in the quarter ending December 31, 2024, with 2.39% growth.
Revenue
1.19B EUR
Revenue Growth
+3.24%
P/S Ratio
4.63
Revenue / Employee
358.35K EUR
Employees
3,308
Market Cap
4.54B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
Dec 31, 2022 | 1.36B | 123.48M | 9.98% |
Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
HSBC Holdings | 48.93B |
Shell | 227.10B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |